Guangdong True Health Medical Technology Development Co., Ltd.

HK$46.52As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2697Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (22.99%)
Medical Devices
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$1.658B
ROIC (22.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$52
11.31%
(80.40%)
Hold 11|5|7|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.33
1.33
1.32
1.39
27.44%
25.70%
14.30%
13.50%
Revenue¥M
78.46
81.75
80.89
80.20
4.76%
6.14%
7.76%
7.76%
Peers (US$211.5M)
Cap (US$)
PE
236.3M
17.21x
167.4M
133.1x
Capital
TTM
5Y
10Y
Leveragex
1.435
0.110
0.073
EBIT/Intx
0.063
0.563
0.507
Own earn%
82.41
(58.62)
(60.00)
Sh yield%
46.33
28.69
32.67
Owners
Insiders/Inst%
7.73
47.91
Short interest%
2.06
SBC / revenue%
0.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
5–12
$1 testx
—
Incr. ROIC%
22